PUBLISHER: IMARC | PRODUCT CODE: 1451711
PUBLISHER: IMARC | PRODUCT CODE: 1451711
Transcriptomics Market Report by Type, Technology (Microarray, Real-Time Quantitative Polymerase Chain Reaction, Sequencing Technologies), Application, End User, and Region 2024-2032
The global transcriptomics market size reached US$ 7.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.8 Billion by 2032, exhibiting a growth rate (CAGR) of 5.44% during 2024-2032.
Transcriptomics is the analysis of the ribonucleic acid (RNA) transcripts produced by the genotype of any organism at a specific time, condition, or cell. It links the genome, the proteome, and the cellular phenotype. Transcriptomics encompasses everything relating to RNAs, including their transcription and expression levels, functions, locations, trafficking, and degradation. Transcriptomics utilizes microarray analysis, real-time quantitative polymerase chain reaction (Q-PCR), and sequencing technologies to determine the transcriptional structure of genes. It also assists researchers in characterizing transcriptional activity, focuses on a subset of relevant target genes and transcripts, and identifies genes and pathways that respond to and counteract biotic and abiotic environmental stresses.
Transcriptomics Market Trends:
The increasing demand for personalized medicine across the globe is creating a positive outlook for the market. Transcriptomics is widely used due to the rising number of PCR applications and the improvements in the field, such as the widespread usage of RNA sequencing. In line with this, the rising demand for RNA sequencing in research applications to obtain genetic information is also favoring the market growth. RNA sequencing has completely transformed transcriptome analysis, enabling the quantification of gene expression levels in a single study and the affinity of new genes, splice isoforms, fusion transcripts, and extraordinary research into the world of non-coding RNA. Apart from this, key players are constantly focusing on developing novel instruments and techniques in diseases and diagnosis, which, in turn, is augmenting the market growth. Additionally, the launch of an advanced gene profiling product with whole transcriptome sequencing (WTS) that can provide detailed RNA sequencing analysis is positively influencing the market growth. Besides this, extensive research and development (R&D) activities, increasing demand for transcriptomics due to the outbreak of the Covid-19 disease, and the implementation of various government initiatives and funding for omics are supporting the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global transcriptomics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, technology, application and end user.
Breakup by Type:
Instruments
Consumables
Software
Services
Breakup by Technology:
Microarray
Real-Time Quantitative Polymerase Chain Reaction (Q-PCR)
Sequencing Technologies
Breakup by Application:
Diagnostics and Disease Profiling
Drug Discovery
Others
Breakup by End User:
Academic and Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Becton Dickinson and Company, BGI Group, Bio-Rad Laboratories Inc., Biospyder Technologies Inc., Illumina Inc., Nanostring Technologies Inc., Qiagen, Roche Holding AG, Takara Bio Inc. and Thermo Fisher Scientific Inc. Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report
- 1. What was the size of the global transcriptomics market in 2023?
- 2. What is the expected growth rate of the global transcriptomics market during 2024-2032?
- 3. What are the key factors driving the global transcriptomics market?
- 4. What has been the impact of COVID-19 on the global transcriptomics market?
- 5. What is the breakup of the global transcriptomics market based on type?
- 6. What is the breakup of the global transcriptomics market based on the technology?
- 7. What is the breakup of the global transcriptomics market based on the application?
- 8. What are the key regions in the global transcriptomics market?
- 9. Who are the key players/companies in the global transcriptomics market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Transcriptomics Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Type
- 6.1 Instruments
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Consumables
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Software
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Services
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
7 Market Breakup by Technology
- 7.1 Microarray
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Real-Time Quantitative Polymerase Chain Reaction (Q-PCR)
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Sequencing Technologies
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
8 Market Breakup by Application
- 8.1 Diagnostics and Disease Profiling
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Drug Discovery
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Others
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by End User
- 9.1 Academic and Research Institutes
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Pharmaceutical Companies
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Biotechnology Companies
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
- 9.4 Others
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 China
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 Germany
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Agilent Technologies Inc.
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 Financials
- 15.3.1.4 SWOT Analysis
- 15.3.2 Becton Dickinson and Company
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.2.3 Financials
- 15.3.2.4 SWOT Analysis
- 15.3.3 BGI Group
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.4 Bio-Rad Laboratories Inc.
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 Financials
- 15.3.4.4 SWOT Analysis
- 15.3.5 Biospyder Technologies Inc.
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.6 Illumina Inc.
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.6.3 Financials
- 15.3.6.4 SWOT Analysis
- 15.3.7 Nanostring Technologies Inc.
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.7.3 Financials
- 15.3.8 Qiagen
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.8.3 Financials
- 15.3.8.4 SWOT Analysis
- 15.3.9 Roche Holding AG
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.9.3 Financials
- 15.3.10 Takara Bio Inc.
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.10.3 Financials
- 15.3.11 Thermo Fisher Scientific Inc.
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.11.3 Financials
- 15.3.11.4 SWOT Analysis
- 15.3.1 Agilent Technologies Inc.
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.
List of Figures
- Figure 1: Global: Transcriptomics Market: Major Drivers and Challenges
- Figure 2: Global: Transcriptomics Market: Sales Value (in Billion US$), 2018-2023
- Figure 3: Global: Transcriptomics Market Forecast: Sales Value (in Billion US$), 2024-2032
- Figure 4: Global: Transcriptomics Market: Breakup by Type (in %), 2023
- Figure 5: Global: Transcriptomics Market: Breakup by Technology (in %), 2023
- Figure 6: Global: Transcriptomics Market: Breakup by Application (in %), 2023
- Figure 7: Global: Transcriptomics Market: Breakup by End User (in %), 2023
- Figure 8: Global: Transcriptomics Market: Breakup by Region (in %), 2023
- Figure 9: Global: Transcriptomics (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 10: Global: Transcriptomics (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 11: Global: Transcriptomics (Consumables) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 12: Global: Transcriptomics (Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 13: Global: Transcriptomics (Software) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 14: Global: Transcriptomics (Software) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 15: Global: Transcriptomics (Services) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 16: Global: Transcriptomics (Services) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 17: Global: Transcriptomics (Microarray) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 18: Global: Transcriptomics (Microarray) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 19: Global: Transcriptomics (Real-Time Quantitative Polymerase Chain Reaction (Q-PCR)) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 20: Global: Transcriptomics (Real-Time Quantitative Polymerase Chain Reaction (Q-PCR)) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 21: Global: Transcriptomics (Sequencing Technologies) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 22: Global: Transcriptomics (Sequencing Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 23: Global: Transcriptomics (Diagnostics and Disease Profiling) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 24: Global: Transcriptomics (Diagnostics and Disease Profiling) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 25: Global: Transcriptomics (Drug Discovery) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 26: Global: Transcriptomics (Drug Discovery) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 27: Global: Transcriptomics (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 28: Global: Transcriptomics (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 29: Global: Transcriptomics (Academic and Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 30: Global: Transcriptomics (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 31: Global: Transcriptomics (Pharmaceutical Companies) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 32: Global: Transcriptomics (Pharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 33: Global: Transcriptomics (Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 34: Global: Transcriptomics (Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 35: Global: Transcriptomics (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 36: Global: Transcriptomics (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 37: North America: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 38: North America: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 39: United States: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 40: United States: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 41: Canada: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 42: Canada: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 43: Asia-Pacific: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 44: Asia-Pacific: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 45: China: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 46: China: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 47: Japan: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 48: Japan: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 49: India: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 50: India: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 51: South Korea: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 52: South Korea: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 53: Australia: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 54: Australia: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 55: Indonesia: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 56: Indonesia: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 57: Others: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 58: Others: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 59: Europe: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 60: Europe: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 61: Germany: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 62: Germany: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 63: France: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 64: France: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 65: United Kingdom: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 66: United Kingdom: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 67: Italy: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 68: Italy: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 69: Spain: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 70: Spain: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 71: Russia: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 72: Russia: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 73: Others: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 74: Others: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 75: Latin America: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 76: Latin America: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 77: Brazil: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 78: Brazil: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 79: Mexico: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 80: Mexico: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 81: Others: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 82: Others: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 83: Middle East and Africa: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 84: Middle East and Africa: Transcriptomics Market: Breakup by Country (in %), 2023
- Figure 85: Middle East and Africa: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 86: Global: Transcriptomics Industry: SWOT Analysis
- Figure 87: Global: Transcriptomics Industry: Value Chain Analysis
- Figure 88: Global: Transcriptomics Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Transcriptomics Market: Key Industry Highlights, 2023 and 2032
- Table 2: Global: Transcriptomics Market Forecast: Breakup by Type (in Million US$), 2024-2032
- Table 3: Global: Transcriptomics Market Forecast: Breakup by Technology (in Million US$), 2024-2032
- Table 4: Global: Transcriptomics Market Forecast: Breakup by Application (in Million US$), 2024-2032
- Table 5: Global: Transcriptomics Market Forecast: Breakup by End User (in Million US$), 2024-2032
- Table 6: Global: Transcriptomics Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 7: Global: Transcriptomics Market: Competitive Structure
- Table 8: Global: Transcriptomics Market: Key Players
